LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

2,564
Mkt Cap
$4.06B
Volume
234,918.00
52W High
$212.49
52W Low
$93.58
PE Ratio
99.18
LGND Fundamentals
Price
$199.03
Prev Close
$206.05
Open
$209.13
50D MA
$184.31
Beta
0.97
Avg. Volume
141,175.57
EPS (Annual)
-$0.2204
P/B
4.26
Rev/Employee
$2.46M
Loading...
Loading...
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
68

Frequently Asked Questions

What is Market Cap of Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
What is the 52-week high for Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
What is the 52-week low for Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
What is Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B stock price today?
What was Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B stock price yesterday?
What is the PE ratio of Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
What is the Price-to-Book ratio of Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
What is the 50-day moving average of Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B?
How many employess does Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B has?

Latest LGND News

View

Advertisement|Remove ads.

Advertisement|Remove ads.